Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 11/20 | 0.48 |
| ▸ | BCHE | P06276 | 8/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | SLC22A2 | O15244 | 1/20 | 0.31 |
| ▸ | SLC22A1 | O15245 | 1/20 | 0.31 |
| ▸ | SLC22A3 | O75751 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.31 |
| ▸ | APOBEC3A | P31941 | 1/20 | 0.31 |
| ▸ | EIF4H | Q15056 | 1/20 | 0.31 |
| ▸ | APOBEC3G | Q9HC16 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19601115 | 0.92 | ACHE (0.51) | ACHEBCHEALDH1A1HPGD | |
| SCHEMBL19601118 | 0.87 | ACHE (0.47) | ACHEBCHE | |
| SCHEMBL19607338 | 0.81 | ACHE (0.39) | ACHEBCHEALDH1A1HPGDSLC22A2 | |
| SCHEMBL19601122 | 0.80 | HTT (0.50) | ACHESLC6A4 | |
| SCHEMBL19607291 | 0.80 | ACHE (0.51) | ACHEBCHE | |
| SCHEMBL19601106 | 0.78 | ACHE (0.51) | ACHEBCHE | |
| SCHEMBL19601114 | 0.77 | ACHE (0.41) | ACHEBCHEALDH1A1HPGD | |
| SCHEMBL19601116 | 0.75 | ACHE (0.58) | ACHEBCHEALDH1A1HPGD | |
| SCHEMBL17384312 | 0.75 | SLC22A2 (0.48) | ACHEBCHESLC22A2SLC22A1SLC22A3 | |
| SCHEMBL19601087 | 0.73 | ACHE (0.44) | ACHEBCHEALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10310350-B2 | Organic compound, electrochromic compound, and electrochromic element, optical filter, lens unit, imaging device, and window component having same | CANON KABUSHIKI KAISHA (JP) | 2019-06-04 | — | — | US | disclosed |
| US-20170329195-A1 | ORGANIC COMPOUND, ELECTROCHROMIC COMPOUND, AND ELECTROCHROMIC ELEMENT, OPTICAL FILTER, LENS UNIT, IMAGING DEVICE, AND WINDOW COMPONENT HAVING SAME | CANON KABUSHIKI KAISHA (JP) | 2017-11-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10310350-B2 | Organic compound, electrochromic compound, and electrochromic element, optical filter, lens unit, imaging device, and window component having same | KCNJ2, KCNH3, KCNN2 | ACHE 416/4885BCHE 2668/4885ALDH1A1 2072/4885 |
| US-20170329195-A1 | ORGANIC COMPOUND, ELECTROCHROMIC COMPOUND, AND ELECTROCHROMIC ELEMENT, OPTICAL FILTER, LENS UNIT, IMAGING DEVICE, AND WINDOW COMPONENT HAVING SAME | KCNJ2, KCNH3, KCNN2 | ACHE 416/4885BCHE 2668/4885ALDH1A1 2072/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.